ERBB Receptor Regulation of ESX/ELF3 Promotes Invasion in Breast Epithelial Cells
The Open Cancer Journal · 2010
DOI: 10.2174/1874079001003010089 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Cancer Journal, 2010. Verfasst von Jean-Philippe Coppe und 8 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref).
Abstract (Originalsprache)
ERBB2 amplification and overexpression in human breast cancer is associated with poor outcome.However, over-expression of ERBB2 alone is an early event in breast tumorigenesis, suggesting secondary events are required for progression.Here we demonstrate that the Ets transcription factor, ESX, induces an invasive phenotype in breast epithelial cells mediated through transcriptional targets of ESX.In non-transformed cells this process is regulated by EGF signaling.Expression of ERBB2 facilitates EGF-independent regulation of ESX levels, thus promoting invasion.Our data define mechanisms by which ERBB2 overexpression promotes breast cancer invasiveness and progression, and provide a model to understand the clinical behavior of this subset of human tumors and identify potential therapeutic targets to improve patient outcome.
Zitieren
APA
Coppe, J., Amend, C., Semeiks, J., Baehner, F. L., Bayani, N., Campisi, J., Benz, C. C., Gray, J. W., & Neve, R. M. (2010). ERBB Receptor Regulation of ESX/ELF3 Promotes Invasion in Breast Epithelial Cells. The Open Cancer Journal. https://doi.org/10.2174/1874079001003010089
Vancouver
Coppe J, Amend C, Semeiks J, Baehner FL, Bayani N, Campisi J, et al. ERBB Receptor Regulation of ESX/ELF3 Promotes Invasion in Breast Epithelial Cells. The Open Cancer Journal. 2010. doi:10.2174/1874079001003010089
BibTeX
@article{Coppe2010,
author = {Coppe, Jean-Philippe and Amend, Clifton and Semeiks, Jeremy and Baehner, Frederick L. and Bayani, Nora and Campisi, Judith and Benz, Christopher C. and Gray, Joe W. and Neve, Richard M.},
title = {ERBB Receptor Regulation of ESX/ELF3 Promotes Invasion in Breast Epithelial Cells},
journal = {The Open Cancer Journal},
year = {2010},
doi = {10.2174/1874079001003010089}
}
EUVIMED